# Tolvaptan/Ultrafiltration in the Treatment of Acute Heart Failure

> **NCT01863511** · PHASE4 · COMPLETED · sponsor: **The Christ Hospital** · enrollment: 45 (actual)

## Conditions studied

- Acute Decompensated Heart Failure

## Interventions

- **DRUG:** loop diuretic
- **DRUG:** tolvaptan
- **PROCEDURE:** ultrafiltration

## Key facts

- **NCT ID:** NCT01863511
- **Lead sponsor:** The Christ Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2016-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01863511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01863511, "Tolvaptan/Ultrafiltration in the Treatment of Acute Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01863511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*